pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
PFIZER · news · pharmadog
← back to PFIZER
News mentioning PFIZER
194
stories
May 29, 26
STAT+: At ASCO, positive data for Bristol in multiple myeloma and Pfizer in lung cancer
stat
May 29, 26
STAT+: Pharmalittle: We’re reading about Replimune drug getting third try at FDA approval, a Pfizer deal in China, and more
stat
May 29, 26
STAT+: Allogene CEO David Chang stepping down
stat
May 29, 26
STAT+: Up and down the ladder: The latest comings and goings
stat
May 29, 26
Pfizer, Innovent strike $10B cancer drug deal
biopharma dive
May 29, 26
Pfizer strikes Innovent deal worth up to $10.5B for a dozen cancer programs
endpoints
May 15, 26
Biotech leaders campaign for Pazdur; Takeda to lay off 4,500 workers
biopharma dive
May 14, 26
AstraZeneca follows Merck with Phase 3 win in bladder cancer
endpoints
May 12, 26
STAT+: Hims’ sales miss as telehealth competition grows
stat
May 12, 26
Arvinas, Pfizer find new partner for ‘Protac’ breast cancer drug
biopharma dive
May 12, 26
Pfizer and Arvinas give disappointing breast cancer drug to Rigel
endpoints
May 12, 26
GU Cancer Experts Highlight Top Abstracts to Watch During ASCO 2026
onclive
May 12, 26
A year after Vertex’s big launch, pain drug research faces a pivotal moment
biopharma dive
May 8, 26
Capivasertib/Fulvestrant Yields Numerical OS Advantage in PIK3CA/AKT1/PTEN–Altered Breast Cancer
onclive
May 8, 26
Giants of Cancer Care Announces the 14th Annual Class of Inductees
onclive
May 8, 26
Former FDA leaders, pharma speak out on mifepristone
stat
May 6, 26
Neoadjuvant T-DXd Followed by THP Improves RCB in HER2+ Breast Cancer
onclive
May 6, 26
Cases and Conversations™: Next-Generation Pathology Advances and Considerations for Precision Care in Non–Small Cell Lung Cancer
onclive
May 6, 26
CellCentric raises $220M for a ‘transformative’ multiple myeloma medicine
biopharma dive
May 5, 26
Pfizer's Albert Bourla says he has no mega-merger plans
endpoints
May 5, 26
Pfizer ends Trillium-related development as R&D spend jumps
endpoints
May 5, 26
STAT+: Are analysts too quick to gloss over Lilly’s liver case?
stat
May 4, 26
UCB to acquire maker of antibody treatments for autoimmune diseases
stat
May 1, 26
Arvinas’ ‘Protac’ breast cancer drug cleared by FDA
biopharma dive
May 1, 26
FDA approves Pfizer and Arvinas' breast cancer drug despite underwhelming data
endpoints
May 1, 26
STAT+: Her daughter Mila got a bespoke medicine. Now she’s starting a new biotech to make more
stat
Apr 30, 26
Remembering J. Craig Venter: a relentless scientist who changed biotech — and was all too easily misunderstood
stat
Apr 30, 26
STAT+: Katherine Szarama named acting director of FDA’s vaccines and biologics center
stat
Apr 30, 26
STAT+: FDA wants to exclude weight loss drugs from a compounding list
stat
Apr 30, 26
STAT+: Five-way obesity drug is super effective — in mice
stat
← prev
page 6 of 7
next →
